𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bone marrow polyamines in children with acute leukemia as related to remission status, therapy, and cellularity of specimens

✍ Scribed by Miale, Thomas D. ;Rennert, Owen M. ;Lawson, Daniel L. ;Shukla, Jayesh B. ;Frias, Jaime L.

Book ID
102949960
Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
608 KB
Volume
3
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Measurements of polyamines have potential practicality as biochemical markers of disease activity in adult cancer patients. On this basis, similar measurements were made in children with leukemia and solid tumors. Fluctuations in blood polyamine concentration were studied in relationship to chemotherapy schematics, cellularity and composition of blood and bone marrow specimens, and remission status of patients. Our results indicate that each of these factors may influence these determinations and consequently their clinical usefulness.

πŸ“œ SIMILAR VOLUMES

Significance of common acute lymphoblast
Significance of common acute lymphoblastic leukemia antigen (cALLA) positive cells in bone marrow of children off therapy in complete remission
✍ S. E. Self; S. Morgan; O. Grush; M. F. La Via πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 339 KB

Bone marrows from 21 children with acute lymphoblastic leukemia in complete remission (CR) and off therapy for 14 months to 10 years were examined by flow cytometry with a panel of monoclonal antibodies. Significant percentages of CALLA+ cells of low fluorescence intensity were present up to 9 years

Comparison of the cellularity and presen
Comparison of the cellularity and presence of residual leukemia in bone marrow aspirate and biopsy specimens in pediatric patients with acute lymphoblastic leukemia (ALL) at day 7–14 of chemotherapy
✍ Kidd, Pamela G.; Saminathan, Thamarai; Drachtman, Richard A.; Ettinger, Lawrence πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 23 KB πŸ‘ 3 views

Background. Many pediatric chemotherapy protocols for treatment of ALL require a bone marrow examination at day 7 or day 14 after initiation of therapy. The usefulness of a bone marrow biopsy, in addition to an aspirate, has been a frequently asked question. Procedure. This study addresses the eval